Emergency use authorization for Baricitinib

“The Emergency Use Authorization (EUA) of a drug without Phase 4 clinical trials allows to expand the scope of trials outside laboratory among the public.” Critically comment highlighting the ethical concerns arising out of large vaccination drives administering EUA drugs.